Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02478593

Impact of Patient Education on Benzodiazepine Use in the Elderly

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Vermont · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

The overall goal of this research is to develop and test strategies to decrease potentially inappropriate medication use among the elderly.

Detailed description

Specifically, the purpose of the study is to determine whether direct patient education is effective in decreasing benzodiazepine use in seniors.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEducational bookletParticipants in the intervention group will receive an 8-page booklet that includes a list of generic and brand benzodiazepine names, benzodiazepine medication knowledge test, information about the associated risks of benzodiazepine use, and a list of safe alternative to their potentially inappropriate medication, as well as a stepwise tapering method. Recommendations to discuss decreasing use of benzodiazepines with physicians as well as to consult physicians before stopping any medication are also advised in the booklet. Participants in the control group will receive a booklet, produced by the Centers for Disease Control and Prevention, containing information regarding the important of exercise for seniors.

Timeline

Start date
2015-06-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2015-06-23
Last updated
2021-10-06

Source: ClinicalTrials.gov record NCT02478593. Inclusion in this directory is not an endorsement.